AdalimumabTuberculosis and immune reconstitution inflammatory syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1957卷 / 1期

关键词：

D O I：

10.1007/s40278-023-39143-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[31] NatalizumabProgressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2015, 1580 (1) : 270 - 270
[32] NatalizumabProgressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2020, 1802 (1) : 216 - 216
[33] NatalizumabProgressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2014, 1496 (1) : 31 - 31
[34] FingolimodProgressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2019, 1769 (1) : 203 - 203
[35] Efavirenz/lamivudine/stavudineCryptococcal immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2014, 1497 (1) : 18 - 18
[36] AntiretroviralsAutoimmune hepatitis induced by immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2016, 1628 (1) : 44 - 44
[37] AntiretroviralsInsulin resistance associated with immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2011, 1361 (1) : 8 - 8
[38] FingolimodProgressive multifocal leucoencephalopathy and immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2018, 1692 (1) : 147 - 147
[39] Lamivudine/nevirapine/tenofovirVitiligo immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2018, 1695 (1) : 235 - 235
[40] AntitubercularsParadoxical tuberculosis-immune reconstitution inflammatory syndrome: case report
[J]. Reactions Weekly, 2021, 1865 (1) : 72 - 72

← 1 2 3 4 5 →